Scilex Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2012-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.scilexpharma.com
Comparative Pharmacokinetic Study of Lidocaine Patch 1.8% (ZTlido™) and Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2019-11-04
- Last Posted Date
- 2019-11-04
- Lead Sponsor
- Scilex Pharmaceuticals, Inc.
- Target Recruit Count
- 54
- Registration Number
- NCT04149938
Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2019-10-30
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- Scilex Pharmaceuticals, Inc.
- Target Recruit Count
- 58
- Registration Number
- NCT04144192
Corticosteroid Lumbar Epidural Analgesia for Radiculopathy
Phase 3
Completed
- Conditions
- Lumbosacral Radicular Pain
- Interventions
- Drug: PlaceboDrug: SP-102
- First Posted Date
- 2017-12-13
- Last Posted Date
- 2022-09-19
- Lead Sponsor
- Scilex Pharmaceuticals, Inc.
- Target Recruit Count
- 401
- Registration Number
- NCT03372161
- Locations
- 🇺🇸
Semnur Research Site 49, Saint Petersburg, Florida, United States
🇺🇸Semnur Research Site 13, Tampa, Florida, United States
🇺🇸Semnur Research Site 48, Charleston, South Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath